Efgartigimod
argenx
['argenx']
the #argonauts checking back in from the first #itp plenary session in 15 years! this is our highlight of #ash22 - presenting data from our advance iv study for people with primary immune thrombocytopenia. #togetherwediscover 
We’re a global immunology company using co-creation to develop potential therapies for people with severe autoimmune diseases and cancer.